highlights the incredible work our portfolio companies are doing to improve the health of people & planet

lands $65M from investors including Microsoft & Google to expand clean energy marketplace services

raises $100M Series A to build laser-driven nuclear fusion prototype system

announces a milestone $100M+ partnership with Regeneron to develop in-vivo CRISPR-based gene editing therapies

interviewed our co-founder Paul Straub on how Recurrent is transforming the used EV market

wins exclusive US Department of Energy award to further develop their nuclear fusion technology

announces oversubscribed financing, bringing total Series B round to US$119 Million

founder Christine Moseley in Newsweek feature on women entrepreneurs creating new businesses in record numbers

partners with Google to help all organizations accelerate their journey to 24/7 carbon-free energy

raises $17M oversubscribed seed round to develop small molecule drugs that hit un-druggable proteins